References
- Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.Candidemia in non-neutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008;36:2034–2039.
- Chimenti F, Bizzarri B, Maccioni E, Seci D, Bolasco A, Fioravanti R, Chimenti P, Granese A, Carradori S, Rivenera D, Lilli D, Zicari A, Distinto S. Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. Bioorg Med Chem Lett 2007;17:4635–4640.
- Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40–79.
- Schiaffella F, Macchiarulo A, Milanese L, Vecchiarelli A, Costantino G, Pietrella D, Fringuelli R. Design, synthesis, and microbiological evaluation of new Candida albicans CYP51 inhibitors. J Med Chem 2005;48:7658–7666.
- Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138–1147.
- Polak A. The past, present and future of antimycotic combination therapy. Mycoses 1999;42:355–370.
- Musiol R, Jampilek J, Buchta V, Silva L, Niedbala H, Podeszwa B et al. Antifungal properties of new series of quinoline derivatives. Bioorg Med Chem 2006;14:3592–3598.
- Rao VS, Srinivas K. Modern drug discovery process. J Bioinform Seq Anal 2011;2: 89–94.
- Nussbaumer P, Dorfstätter G, Leitner I, Mraz K, Vyplel H, Stütz A. Synthesis and structure-activity relationships of naphthalene-substituted derivatives of the allylamine antimycotic terbinafine. J Med Chem 1993;36:2810–2816.
- Gokhale VM, Kulkarni VM. Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models. Bioorg Med Chem 2000;8:2487–2499.
- Ates-Alagoz Z, Yildiz S, Buyukbingol E. Antimicrobial activities of some tetrahydronaphthalene-benzimidazole derivatives. Chemotherapy 2007;53:110–113.
- Raj AA, Raghunathan R, SrideviKumari MR, Raman N. Synthesis, antimicrobial and antifungal activity of a new class of spiro pyrrolidines. Bioorg Med Chem 2003;11:407–419.
- Suresh M, Lavanya P, Raju KN, Jonnalagadda SB, Rao CV. Synthesis and biological studies of novel 2-(4-substitutedbenzylthio)-5-amino-6-(benzo[d]thiazol-2-yl)-7-(4-chlorophenyl)pyrido-[2,3-d]-pyrimidin-4(3H)-one derivatives. Org Commun 2011;4:33–41.
- Turan-Zitouni G, Özdemir A, Kaplancıklı ZA, Revial G, Demirci F. Synthesis and antimicrobial activity evaluation of new hydrazide derivatives. Turk J Pharm Sci 2011;8:199–206.
- Vicini P, Zani F, Cozzini P, Doytchinova I. Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem 2002;37:553–564.
- Metwally KA, Abdel-Aziz LM, Lashine el-SM, Husseiny MI, Badawy RH. Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: synthesis and preliminary evaluation as antimicrobial agents. Bioorg Med Chem 2006;14:8675–8682.
- Özdemir A, Turan-Zitouni G, Kaplancikli ZA, İşcan G, Khanc S, Demirci F. Synthesis and the selective antifungal activity of 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinederivatives. Eur J Med Chem 2010;45:2080–2084.
- Sakaguchi H. N-Benzyl-4-alkynyloxybenzenepropanamides, agrochemical fungicides containing them, and plant disease control using them. Jpn Kokai Tokkyo Koho 2005; 66:JP2005314352.
- Turan-Zitouni G, Kaplancikli ZA, Erol K, Kiliç FS. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco 1999;54:218–223.
- Janssen AM, Scheffer JJ, Baerheim Svendsen A. Antimicrobial activity of essential oils: a 1976-1986 literature review. Aspects of the test methods. Planta Med 1987;53:395–398.
- NCCLS, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard, second ed., NCCLS document M27-A2 [ISBN 1-56238-469-4].